Eieling Technology was selected into the “Forbes Asia 100 To Watch 2023” list released by the authoritative American magazine “Forbes” on August 29.
Eieling Technology established Eieling Technology (Shenzhen) Limited and Eieling Technology (Shanghai) Limited in Shenzhen and Shanghai respectively in early 2023, and obtained ISO13485 certification.
With its innovative product Liverscan, Eieling Technology stood out from more than 550 participating companies and became one of the 23 biotech and healthcare startups on the list.
Eieling Technology (Hong Kong) Category: Biotech and Healthcare
Founded: 2018 CEO: Jia Xiaojia
Major backers: Hong Kong Polytechnic University, Hong Kong Innovation and Technology Commission, Hong Kong Science Park
Eieling Technology aims to simplify liver health checks with its portable liver bomb, which is currently being used in clinical studies in Hong Kong and mainland China, and plans to expand into Southeast Asia next year.
Liverscan is the world’s first handheld wireless liver elastometer independently developed by Eieling Technology. This device integrates transient elastography (TE) and real-time ultrasound image guidance into a composite probe. Through real-time image guidance, it greatly improves cost-effectiveness and accuracy, focuses on the screening of progressive liver fibrosis and early cirrhosis, assists doctors in providing HCC risk warnings, effectively blocks the progression of chronic liver disease, and truly achieves “early detection, early diagnosis, and early treatment.”
Eieling Technology established Eieling Technology (Shenzhen) Limited and Eieling Technology (Shanghai) Limited in Shenzhen and Shanghai respectively in early 2023, and obtained ISO13485 certification.